Farley J. Abad

Array ( [id] => 1314572 [patent_doc_number] => 06610834 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-26 [patent_title] => 'Human IgM antibodies to chemokine receptors' [patent_app_type] => B1 [patent_app_number] => 09/684813 [patent_app_country] => US [patent_app_date] => 2000-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 27 [patent_no_of_words] => 8119 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610834.pdf [firstpage_image] =>[orig_patent_app_number] => 09684813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1284762 [patent_doc_number] => 06638771 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Composition and method for diagnosing auto-immune hepatitis' [patent_app_type] => B1 [patent_app_number] => 09/668286 [patent_app_country] => US [patent_app_date] => 2000-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5353 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638771.pdf [firstpage_image] =>[orig_patent_app_number] => 09668286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1145703 [patent_doc_number] => 06773908 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-10 [patent_title] => 'Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV)' [patent_app_type] => B1 [patent_app_number] => 09/601326 [patent_app_country] => US [patent_app_date] => 2000-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 109 [patent_figures_cnt] => 129 [patent_no_of_words] => 59978 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/773/06773908.pdf [firstpage_image] =>[orig_patent_app_number] => 09601326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1275446 [patent_doc_number] => 06649747 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-18 [patent_title] => 'Composition and method for diagnosing auto-immune hepatitis' [patent_app_type] => B1 [patent_app_number] => 09/668283 [patent_app_country] => US [patent_app_date] => 2000-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5119 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649747.pdf [firstpage_image] =>[orig_patent_app_number] => 09668283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 644721 [patent_doc_number] => 07118740 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-10 [patent_title] => 'Method for limiting the growth of cancer cells using an attenuated measles virus' [patent_app_type] => utility [patent_app_number] => 09/668196 [patent_app_country] => US [patent_app_date] => 2000-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9843 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/118/07118740.pdf [firstpage_image] =>[orig_patent_app_number] => 09668196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1413475 [patent_doc_number] => 06514500 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-04 [patent_title] => 'Long lasting synthetic glucagon like peptide GLP- ' [patent_app_type] => B1 [patent_app_number] => 09/657332 [patent_app_country] => US [patent_app_date] => 2000-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21759 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514500.pdf [firstpage_image] =>[orig_patent_app_number] => 09657332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1387741 [patent_doc_number] => 06541013 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Methods and compositions for suppressing bovine leukemia virus with a Shiga toxin polypeptide' [patent_app_type] => B1 [patent_app_number] => 09/615179 [patent_app_country] => US [patent_app_date] => 2000-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 14472 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541013.pdf [firstpage_image] =>[orig_patent_app_number] => 09615179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1071586 [patent_doc_number] => 06841168 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-11 [patent_title] => 'Method for the preservation of biologically-active material' [patent_app_type] => utility [patent_app_number] => 10/018834 [patent_app_country] => US [patent_app_date] => 2000-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5160 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/841/06841168.pdf [firstpage_image] =>[orig_patent_app_number] => 10018834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 634285 [patent_doc_number] => 07129342 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-31 [patent_title] => 'Infectious cDNA clone of GB virus B and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/009002 [patent_app_country] => US [patent_app_date] => 2000-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8724 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/129/07129342.pdf [firstpage_image] =>[orig_patent_app_number] => 10009002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 757389 [patent_doc_number] => 07015033 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-03-21 [patent_title] => 'Co-expression of recombination proteins' [patent_app_type] => utility [patent_app_number] => 09/577601 [patent_app_country] => US [patent_app_date] => 2000-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 8563 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015033.pdf [firstpage_image] =>[orig_patent_app_number] => 09577601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 720588 [patent_doc_number] => 07049428 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-23 [patent_title] => 'HCV variants' [patent_app_type] => utility [patent_app_number] => 09/576989 [patent_app_country] => US [patent_app_date] => 2000-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 28070 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049428.pdf [firstpage_image] =>[orig_patent_app_number] => 09576989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 541565 [patent_doc_number] => 07163686 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-01-16 [patent_title] => 'Protein A based binding domains with desirable activities' [patent_app_type] => utility [patent_app_number] => 09/979383 [patent_app_country] => US [patent_app_date] => 2000-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 20611 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/163/07163686.pdf [firstpage_image] =>[orig_patent_app_number] => 09979383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1359895 [patent_doc_number] => 06573244 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-03 [patent_title] => 'Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus neurotoxins' [patent_app_type] => B1 [patent_app_number] => 09/570022 [patent_app_country] => US [patent_app_date] => 2000-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12783 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/573/06573244.pdf [firstpage_image] =>[orig_patent_app_number] => 09570022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 714528 [patent_doc_number] => 07052697 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-30 [patent_title] => 'Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses' [patent_app_type] => utility [patent_app_number] => 10/018290 [patent_app_country] => US [patent_app_date] => 2000-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20174 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/052/07052697.pdf [firstpage_image] =>[orig_patent_app_number] => 10018290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1056095 [patent_doc_number] => 06855318 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-02-15 [patent_title] => 'Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes' [patent_app_type] => utility [patent_app_number] => 09/566266 [patent_app_country] => US [patent_app_date] => 2000-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14842 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/855/06855318.pdf [firstpage_image] =>[orig_patent_app_number] => 09566266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4547492 [patent_doc_number] => 07820161 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-10-26 [patent_title] => 'Treatment of autoimmune diseases' [patent_app_type] => utility [patent_app_number] => 09/564288 [patent_app_country] => US [patent_app_date] => 2000-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16082 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/820/07820161.pdf [firstpage_image] =>[orig_patent_app_number] => 09564288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1021249 [patent_doc_number] => 06887676 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-03 [patent_title] => 'Method to type prion proteins' [patent_app_type] => utility [patent_app_number] => 09/958517 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7488 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887676.pdf [firstpage_image] =>[orig_patent_app_number] => 09958517 [rel_patent_id] =>[rel_patent_doc_number] =>)